Article
Pentagalloylglucose ameliorates acute respiratory distress syndrome by targeting PFKFB2-mediated neutrophil glycolysis and inflammation
2026-08-11
Abstract excerpt
<title>Abstract</title> <p>Background Acute respiratory distress syndrome (ARDS) is a life-threatening clinical syndrome characterized by acute hypoxemic respiratory failure, with mortality rates ranging from 30% to 50% in critically ill patients. Despite decades of research, effective targeted therapies remain limited. Metabolic reprogramming and excessive neutrophil-mediated inflammation are central pathologic...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 193225ff-ff1f-5fa5-a8dc-0c213cbe1673
- DOI
- 10.21203/rs.3.rs-10380478/v1
